ArticleMedicine2026
Predictors of sentinel lymph node metastasis in cT1-2 cN0 breast cancer: A retrospective cohort study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to identify independent predictors of sentinel lymph node (SLN) metastasis in clinically node-negative (cN0) breast cancer and evaluate the diagnostic accuracy of intraoperative frozen section (FS). A retrospective analysis was conducted on 72 female patients with early-stage (cT1-2 cN0) invasive breast cancer who underwent SLN biopsy. Clinical, pathological, and radiological parameters were evaluated. Univariate and multivariate logistic regression analyses were performed to determine independent predictors of metastasis. Intraoperative FS results were compared with definitive paraffin pathology. Definitive permanent paraffin section analysis confirmed SLN metastasis in 41.7% (n = 30) of patients. The false negative rate for intraoperative FS was 23.3%. Multivariate analysis identified lymphovascular invasion (LVI; OR = 8.22, P = .001) and elevated continuous progesterone receptor expression (OR = 1.02, P = .008) as significant independent predictors of initial SLN metastasis. Conversely, human epidermal growth factor receptor 2 positivity demonstrated a significant inverse relationship with nodal involvement (OR = 0.20, P = .010). Other clinicopathological parameters, including Ki-67, were not significantly associated. Our findings suggest that initial SLN metastasis may be primarily associated with the presence of LVI, elevated progesterone receptor expression, and human epidermal growth factor receptor 2 status. Preoperative identification of these specific markers could optimize risk stratification and support the strategic consideration of neoadjuvant systemic therapy to mitigate the diagnostic limitations of intraoperative staging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.